Home › Eierstokkanker › Washington › Seattle
Eierstokkanker klinische studies in Seattle, WA
30 studies voor Eierstokkanker zoeken deelnemers op locaties in en rond Seattle (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RekruterenFase 2
- Swedish Medical Center-First Hill, Seattle
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RekruterenFase 1/2
- University of Washington, Fred Hutchinson Cancer Center, Seattle
Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study
Rekruteren
- University of Washington, Seattle
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
RekruterenObservatieonderzoek
- Fred Hutchinson Cancer Center, Seattle
A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
RekruterenFase 1/2
- Seattle Cancer Care Alliance at South Lake Union - G3630, Seattle
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
RekruterenFase 3
- Swedish Medical Center, Seattle
- Fred Hutchinson Cancer Center, Seattle
A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
RekruterenFase 2
- Virginia Mason Hospital and Medical Center /ID# 277259, Seattle
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
RekruterenFase 1
- University of Washington Fred Hutchinson, Seattle
IGFBP-2 Vaccine to Prevent Ovarian Cancer Progression in Patients With Serologic Detection of Recurrence
RekruterenFase 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
RekruterenFase 3
- Virginia Mason Medical Center, Seattle
- Fred Hutchinson Cancer Center, Seattle
Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer
RekruterenFase 2
- Swedish Cancer Institute, Seattle
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Rekruteren
- Swedish Medical Center-Ballard Campus, Seattle
- Fred Hutchinson Cancer Center, Seattle
- Swedish Medical Center-Cherry Hill, Seattle
- en nog 3
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
RekruterenFase 3
- Swedish Medical Center-Ballard Campus, Seattle
- Fred Hutchinson Cancer Center, Seattle
- Swedish Medical Center-Cherry Hill, Seattle
- en nog 4
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
RekruterenFase 1
- Fred Hutchinson Cancer Center, Seattle
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
RekruterenFase 1/2
- Swedish Cancer Institute, Seattle
Clinical Pre-screening Protocol for Ovarian Cancer
RekruterenObservatieonderzoek
- Swedish Center for Research and Innovation, Seattle
A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
RekruterenFase 2/3
- University of Washington - Seattle Cancer Care Alliance, Seattle
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
RekruterenFase 2
- University of Washington School of Medicine, Seattle
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
RekruterenFase 1
- Swedish Cancer Institute, Seattle
- Swedish Medical Center, Seattle
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
RekruterenFase 1/2
- Fred Hutchinson Cancer Center, Seattle
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
RekruterenFase 1/2
- Fred Hutchinson Cancer Center, Seattle
Adapted Helping Ovarian Cancer Patients Cope Intervention to Address Burnout for Gynecologic Oncology Clinicians
RekruterenGezonde vrijwilligers welkom
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
RekruterenFase 1/2
- Fred Hutchinson Cancer Center, Seattle
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
RekruterenFase 1/2
- Fred Hutchinson Cancer Center, Seattle
Clonal Hematopoiesis and Therapy-Emergent Myeloid Neoplasms in Patients With Cancers, CHANCES Study
RekruterenObservatieonderzoek
- Fred Hutch/University of Washington Cancer Consortium, Seattle
TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention
Rekruteren
- University of Washington, Seattle
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
RekruterenFase 1/2
- Fred Hutchinson Cancer Center, Seattle
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
RekruterenFase 1
- Fred Hutchinson Cancer Center, Seattle
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruterenObservatieonderzoek
- Massive Bio SYNERGY-AI site, Seattle
Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer
RekruterenObservatieonderzoek
- The Swedish Hospital, Seattle
Eierstokkanker studies in andere steden
- Houston, TX89 studies
- New York City, NY69 studies
- Boston, MA61 studies
- Los Angeles, CA50 studies
- Nashville, TN49 studies
- Arlington, VA46 studies
- Philadelphia, PA44 studies
- Columbus, OH39 studies
- St. Louis, MO38 studies
- Chicago, IL36 studies
- San Antonio, TX31 studies
- Cleveland, OH30 studies
Andere studies in Seattle
- Niet-kleincellige longkanker53 studies
- Kanker (alle vormen)49 studies
- Prostaatkanker42 studies
- Acute myeloïde leukemie41 studies
- Borstkanker39 studies
- Metastatische kanker39 studies
- Colorectale kanker34 studies
- Longkanker33 studies
- Multipel myeloom22 studies
- Blasenkanker21 studies
- Myelodysplastische syndromen21 studies
- Acute lymfoblastaire leukemie21 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.